Retatrutide
Retatrutide is an investigational compound that acts on three receptors — GLP-1, GIP, and glucagon. It is earlier in its research timeline than semaglutide or tirzepatide.
Educational reference only. TrackPep is a tracking and organization tool, not medical advice. Consult a qualified healthcare professional for health decisions.